By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Diagnostics Laboratories (Dx)10.88B77.96%
Biopharma Laboratory Services (BLS)3.1B22.21%
Intercompany eliminations and other-23M-0.16%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
U.S.11.65B83.50%
Europe1.26B9.00%
Other558.07M4.00%
North America487.88M3.50%